Simon Ekman
Karolinska University Hospital(SE)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Growth Hormone and Insulin-like Growth Factors, Protein Kinase Regulation and GTPase Signaling, Neuroendocrine Tumor Research Advances, Ubiquitin and proteasome pathways
Most-Cited Works
- → Clinical Phase I study with an Insulin-like Growth Factor-1 Receptor Inhibitor: Experiences in patients with squamous non-small cell lung carcinoma(2010)51 cited
- → A study of embryonic stem cell‐related proteins in human astrocytomas: Identification of Nanog as a predictor of survival(2013)50 cited
- → Identification of Tyr-762 in the platelet-derived growth factor α-receptor as the binding site for Crk proteins(1998)50 cited
- → Ligand-induced recruitment of Na+/H+-exchanger regulatory factor to the PDGF (platelet-derived growth factor) receptor regulates actin cytoskeleton reorganization by PDGF(2003)49 cited
- → Human Cytomegalovirus Tegument Protein pp65 Is Detected in All Intra- and Extra-Axial Brain Tumours Independent of the Tumour Type or Grade(2014)47 cited
- → SHP-2 is involved in heterodimer specific loss of phosphorylation of Tyr771 in the PDGF β-receptor(2002)44 cited
- → A novel oral insulin-like growth factor-1 receptor pathway modulator and its implications for patients with non-small cell lung carcinoma: A phase I clinical trial(2015)21 cited
- → Microtubule inhibition causes epidermal growth factor receptor inactivation in oesophageal cancer cells(2012)19 cited
- → A phase I pilot study of the insulin-like growth factor 1 receptor pathway modulator AXL1717 in combination with gemcitabine HCl and carboplatin in previously untreated, locally advanced, or metastatic non-small cell lung cancer(2015)17 cited
- A review of dose-dense temozolomide alone and in combination with bevacizumab in patients with first relapse of glioblastoma.(2012)